SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 44 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $3,570 | +26.2% | 2,000 | 0.0% | 0.00% | – |
| Q4 2023 | $2,828 | -19.9% | 2,000 | 0.0% | 0.00% | – |
| Q3 2023 | $3,532 | +4.7% | 2,000 | 0.0% | 0.00% | – |
| Q2 2023 | $3,372 | +74.5% | 2,000 | +100.0% | 0.00% | – |
| Q1 2023 | $1,932 | -48.3% | 1,000 | -50.0% | 0.00% | – |
| Q4 2022 | $3,736 | +24.5% | 2,000 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | +200.0% | 2,000 | +100.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 61,662,000 | $141,593,000 | 5.18% |
| WOLVERINE ASSET MANAGEMENT LLC | 93,891,000 | $215,954,000 | 2.17% |
| LINDEN ADVISORS LP | 30,877,000 | $71,021,000 | 1.15% |
| Verition Fund Management LLC | 14,948,000 | $34,343,000 | 1.13% |
| SSI INVESTMENT MANAGEMENT LLC | 5,167,000 | $11,858,000 | 1.04% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 7,500,000 | $17,246,000 | 0.78% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 11,929,000 | $27,313,000 | 0.64% |
| CSS LLC/IL | 4,144,000 | $9,531,000 | 0.54% |
| AQR Arbitrage LLC | 4,625,000 | $10,626,000 | 0.47% |
| Calamos Advisors LLC | 25,136,000 | $57,829,000 | 0.41% |